BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/27/2025 8:06:32 AM | Browse: 6 | Download: 0
Category |
Endocrinology & Metabolism |
Manuscript Type |
Basic Study |
Article Title |
PI3K/AKT/GSK3β regulatory axis in bone mesenchymal stem cells initiates diabetic myocardial infarction via miR-142-3p
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Ning Gao, Peng-Fei Wu, Ming-Wen Wu, Yu-Meng Li, Xu Liang, Fei-Fei Wang, Xue-Jing Li, Qing-Qing Shen, Tian-Peng Zheng, Xiao-Ling Liu, Yi Sun and Liu-Xue Yang |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Health Commission Project |
Z2014334 |
Natural Science Foundation of Guangxi Province, China |
2020GXNSFAA238036 |
|
Corresponding Author |
Yi Sun, Department of Toxicology, Guilin Medical University, No. 1, Zhiyuan Road, Lingui District, Guilin City, Guangxi Zhuang Autonomous Region, Guilin 541004, Guangxi Zhuang Autonomous Region, China. sunyide163@163.com |
Key Words |
Bones mesenchymal stem cells; Myocardial infarction in diabetes; MiR-142-3p; Liraglutide; Ferroptosis |
Core Tip |
This study demonstrated that using bones mesenchymal stem cells (BMCs) as an intervention can simultaneously reduce blood sugar levels and promote hypoxic myocardial recovery. However, when miR-142-3p expression in BMCs was low, there was a reduced therapeutic efficacy of BMCs and activation of PI3K/AKT/GSK-3β. The regulatory axis regulates changes in the protein expression levels of the ferroptosis-related genes GPX4/CHCHD6. These findings suggest that miR-142-3p via the PI3K/AKT/GSK-3β regulation axis that jointly inhibits ferroptosis, may be one of the therapeutic mechanisms of BMCs in diabetic myocardial infarction. |
Citation |
Gao N, Wu PF, WU MW, Li YM, Liang X, Wang FF, Li XJ, Shen QQ, Zheng TP, Liu XL, Sun Y, Yang LX. PI3K/AKT/GSK3β regulatory axis in bone mesenchymal stem cells initiates diabetic myocardial infarction via miR-142-3p. World J Exp Med 2025; In press |
 |
Received |
|
2024-12-06 08:13 |
 |
Peer-Review Started |
|
2024-12-09 07:11 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-02-28 06:53 |
 |
Revised |
|
2025-03-12 12:43 |
 |
Second Decision |
|
2025-04-27 02:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-04-27 08:06 |
 |
Articles in Press |
|
2025-04-27 08:06 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
2220-315x (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345